Literature DB >> 15745106

Use of methylene blue for detection of specialized intestinal metaplasia in GERD patients presenting for screening upper endoscopy.

Marten B Duncan1, J David Horwhat, Corrinne L Maydonovitch, Ferdanando Ramos, Ramon Colina, Erich Gaertner, Hyun Yang, Roy K H Wong.   

Abstract

The ability of randomly obtained biopsy specimens to identify intestinal metaplasia in the distal esophagus is low. Use of vital staining has been suggested, as stains are taken up by areas histologically identified as specialized intestinal metaplasia (SIM). This study evaluated the role of methylene blue (MB) staining for identification of SIM in GERD patients undergoing a screening endoscopy. Chromoendoscopy of the distal esophagus using 1% MB was performed on 52 GERD patients presenting for their first endoscopy. Biopsies were obtained from areas that were stained darkly, stained lightly, unstained, or macroscopically abnormal. In patients with no MB staining, four-quadrant biopsy of the distal esophagus was performed. Twenty-seven patients (52%) showed staining with MB, while 25 patients did not. Two hundred sixty-six biopsies were obtained. SIM was detected in 11 (21%) subjects (SIM+) but not in the remaining 41 (SIM-). One hundred sixty-five biopsies were unstained (25 SIM+, 140 SIM-) and 101 were stained (12 SIM+, 89 SIM-). The per-biopsy sensitivity and specificity of MB for detection of SIM were 32.4 and 85%, while the per-patient sensitivity and specificity were 63.3 and 51.2%. MB staining for detection of SIM in GERD patients without a macroscopic appearance suggestive of a columnar-lined esophagus is a poor screening tool for SIM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15745106     DOI: 10.1007/s10620-005-1616-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  Vital staining and Barrett's esophagus.

Authors:  M I Canto
Journal:  Gastrointest Endosc       Date:  1999-03       Impact factor: 9.427

Review 2.  Endoscopic surveillance of Barrett's esophagus: risk stratification and cancer risk.

Authors:  G W Falk
Journal:  Gastrointest Endosc       Date:  1999-03       Impact factor: 9.427

3.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.

Authors:  R E Sampliner
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

4.  Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett's esophagus and a normal control group.

Authors:  R Kiesslich; M Hahn; G Herrmann; M Jung
Journal:  Gastrointest Endosc       Date:  2001-01       Impact factor: 9.427

5.  Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus.

Authors:  M I Canto; S Setrakian; J Willis; A Chak; R Petras; N R Powe; M V Sivak
Journal:  Gastrointest Endosc       Date:  2000-05       Impact factor: 9.427

6.  Continuing climb in rates of esophageal adenocarcinoma: an update.

Authors:  W J Blot; S S Devesa; J F Fraumeni
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

7.  Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low-grade dysplasia.

Authors:  L M Gangarosa; S Halter; H Mertz
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

8.  Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus.

Authors:  M I Canto; S Setrakian; R E Petras; E Blades; A Chak; M V Sivak
Journal:  Gastrointest Endosc       Date:  1996-07       Impact factor: 9.427

9.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.

Authors:  W K Hirota; T M Loughney; D J Lazas; C L Maydonovitch; V Rholl; R K Wong
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

10.  Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction.

Authors:  M Pera; A J Cameron; V F Trastek; H A Carpenter; A R Zinsmeister
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

  10 in total
  3 in total

1.  Breast Cancer Sentinel Node Detection: An Alternative Solution for Centers Lacking Nuclear Technology.

Authors:  Mahmoud A Alhussini; Ahmed T Awad; Mohamed H Ashour; Ahmed Abdelateef; Haytham Fayed
Journal:  Breast Care (Basel)       Date:  2016-08-15       Impact factor: 2.860

Review 2.  Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives.

Authors:  Anitha Sriram; Suma Tangirala; Srividya Atmakuri; Sajid Hoque; Sheela Modani; Saurabh Srivastava; Srushti Mahajan; Indrani Maji; Rahul Kumar; Dharmendra Khatri; Jitender Madan; Pankaj Kumar Singh
Journal:  AAPS PharmSciTech       Date:  2021-11-03       Impact factor: 3.246

3.  The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma.

Authors:  N Ormeci; B Savas; S Coban; M Palabiyikoğlu; A Ensari; I Kuzu; N Kursun
Journal:  Surg Endosc       Date:  2008-03       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.